hCINAP regulates the DNA-damage response and mediates the resistance of acute myelocytic leukemia cells to therapy.

MLA

Xu, Ruidan, et al. “HCINAP Regulates the DNA-Damage Response and Mediates the Resistance of Acute Myelocytic Leukemia Cells to Therapy.” Nature Communications, vol. 10, no. 1, Aug. 2019, p. 3812. EBSCOhost, https://doi.org/10.1038/s41467-019-11795-5.

APA

Xu, R., Yu, S., Zhu, D., Huang, X., Xu, Y., Lao, Y., Tian, Y., Zhang, J., Tang, Z., Zhang, Z., Yi, J., Zhu, H.-H., & Zheng, X. (2019). hCINAP regulates the DNA-damage response and mediates the resistance of acute myelocytic leukemia cells to therapy. Nature Communications, 10(1), 3812. https://doi.org/10.1038/s41467-019-11795-5

Chicago

Xu, Ruidan, Shuyu Yu, Dan Zhu, Xinping Huang, Yuqi Xu, Yimin Lao, Yonglu Tian, et al. 2019. “HCINAP Regulates the DNA-Damage Response and Mediates the Resistance of Acute Myelocytic Leukemia Cells to Therapy.” Nature Communications 10 (1): 3812. doi:10.1038/s41467-019-11795-5.